Tian An Medicare (FRA:SMI) 9-Day RSI: 36.42 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SMI Tian An Medicare Ltd FRA:SMI
43 GF Score
Price €0.09
GF Value €0.07
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare 9-Day RSI?

Tian An Medicare FRA:SMI 43 9-Day RSI is 36.42 as of Jul. 17, 2026. GuruFocus rates FRA:SMI with a GF Score™ of 43/100 and a GF Value™ of €0.07 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 698 Healthcare Providers & Services companies, Tian An Medicare ranks better than 98.28% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-17), Tian An Medicare's 9-Day RSI is 36.42.

The industry rank for Tian An Medicare's 9-Day RSI or its related term are showing as below:

FRA:SMI's 9-Day RSI is ranked better than
98.28% of 698 companies
in the Healthcare Providers & Services industry
Industry Median: 50.77 vs FRA:SMI: 36.42

Tian An Medicare  (FRA:SMI) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Tian An Medicare 9-Day RSI Related Terms


FRA:SMI vs HCA, THC, DVA: 9-Day RSI Comparison

For the Medical Care Facilities subindustry, Tian An Medicare's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tian An Medicare 9-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Tian An Medicare's 9-Day RSI falls into.


FRA:SMI
43GF Score
Tian An Medicare Ltd FRA:SMI
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare  (FRA:SMI) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 36.42 mean?
Tian An Medicare (FRA:SMI) has a 9-Day RSI of 36.42 as of Jul. 17, 2026. According to the industry distribution chart, Tian An Medicare ranks #12 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 1.7%.
Is Tian An Medicare's 9-Day RSI too high?
Tian An Medicare's current 9-Day RSI is 36.42. The Healthcare Providers & Services industry median 9-Day RSI is 50.77. Tian An Medicare's value of 36.42 is 28.3% below this industry median. Based on the distribution chart, Tian An Medicare ranks #12 out of 698 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tian An Medicare has a GF Score™ of 43/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #12 out of 698 companies for 9-Day RSI. This places Tian An Medicare in the top 2% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 50.77. Tian An Medicare's value of 36.42 is 28.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.77, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tian An Medicare's current 9-Day RSI of 36.42 is 28.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current 9-Day RSI is 36.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Based on GuruFocus' analysis, Tian An Medicare (FRA:SMI) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.07, compared to a current price of €0.09 — trading 28.6% above its estimated fair value. The current 9-Day RSI is 36.42 and 28.3% below the Healthcare Providers & Services industry median of 50.77. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Tian An Medicare (FRA:SMI), the current 9-Day RSI is 36.42 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (FRA:SMI) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of €0.09 is trading 28.6% above its estimated GF Value™ of €0.07. GuruFocus considers Tian An Medicare to be Modestly Overvalued.

Key valuation signals for FRA:SMI:

  • 9-Day RSI: 36.42
  • GF Value™: €0.07 vs. price of €0.09 (28.6% above fair value)
  • GF Score™: 43/100 with 4 warning signs
  • Industry Position: 28.3% below the Healthcare Providers & Services median (#12 of 698)

No single metric tells the full story. See the FRA:SMI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tian An Medicare Business Description

Other Exchanges 00383:Hong Kong
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score

Get the complete analysis for FRA:SMI

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.07
GF Value